31617-39-7 Usage
Classification
Methylxanthine derivative
Function
Bronchodilator medication
Medical Uses
Treating asthma symptoms
Treating chronic bronchitis symptoms
Treating emphysema symptoms
Mechanism of Action
Relaxing airway muscles
Increasing airflow to the lungs
Inhibiting phosphodiesterase enzyme
Promoting smooth muscle relaxation and bronchodilation
Stimulating the central nervous system
Improving diaphragm contractility
Additional Effects
Anti-inflammatory and immunomodulatory properties
Side Effects
Nausea
Vomiting
Headache
Increased heart rate
Drug Interactions
Can interact with various other medications
Administration
Typically taken orally, though other forms may be available
Precautions
Close monitoring of dosage and potential side effects is necessary due to the risk of side effects and drug interactions.
Check Digit Verification of cas no
The CAS Registry Mumber 31617-39-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,1,6,1 and 7 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 31617-39:
(7*3)+(6*1)+(5*6)+(4*1)+(3*7)+(2*3)+(1*9)=97
97 % 10 = 7
So 31617-39-7 is a valid CAS Registry Number.
InChI:InChI=1/C10H14N4O2/c1-4-13-8-7(12(3)6-11-8)9(15)14(5-2)10(13)16/h6H,4-5H2,1-3H3
31617-39-7Relevant articles and documents
Alkyl migrations in the thermal transformation of 2,6-dialkoxy-7,9-dimethylpurinium iodides leading to 1,3,7-trialkylxanthines
Kowalska,Maslankiewicz
, p. 454 - 459 (2007/10/03)
2,6-Dialkoxy-7,9-dimethylpurinium iodides 1 undergo thermal transformation to 1,3,7-trialkylxanthines 2 as a result of C6O → Nx, C2O → NX, N9 → Nx, and N7 → Nx (when x = 1, 3 or 7) alkyl group migration. Intra-or intermolecular character of rearrangement was studied using deuterium-labelled derivatives of 1, and by cross-over experiment with salts 1a* and 1c. The 1H NMR spectra of 1,3,7-trialkylxanthines 2 (R = Me, Et) are presented.
